release_sha256 string | release_frozen_at string | cik string | company_name string | packet_sha256 string | packet_recorded_at string | source_observed_at string | source_sha256 string | company_url string | fact_id string | concept string | label string | unit string | value_json string | period_start string | period_end string | filed_date string | first_observed_at string | first_source_sha256 string | accession string | form string | source_url string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 00bc722f93f7694896419d2858dbff3595385c79849a8fd6e4aaf50005830608 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 40109000000 | 2023-01-01 | 2023-12-31 | 2024-02-16 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-005348 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 0227015c45d209b827107a4c825ed928cabda969e7e262b56ce4fc631b4ea510 | us-gaap:Assets | Total assets | USD | 73354000000 | null | 2023-06-30 | 2023-08-03 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-027203 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 06ba43d545c10343adecd41b0224dfe09f25605ca495e25be46038c2983c0717 | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 1025000000 | 2024-01-01 | 2024-03-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 08c97ad1777467d10cd9acff6a97b83758485a056bdeec80514d5cee3675191d | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 2202000000 | 2023-01-01 | 2023-12-31 | 2024-02-16 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-005348 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 09b96d0e26525fbb6bba96aaa6b65ebc4a5af322dd4f6aa300dd104f11d11027 | us-gaap:Assets | Total assets | USD | 74438000000 | null | 2022-12-31 | 2023-02-17 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-004026 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 0aae178a6bd2c37e95efe3bbc32dbe2c580081c80dab97ca02b39edcd1e23de0 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1646000000 | 2024-07-01 | 2024-09-30 | 2025-10-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-047131 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 0b4c999a93caf2c16a68dc37bb2413b6b84f491be1469a3a7fd0860962c92f94 | us-gaap:Assets | Total assets | USD | 73017000000 | null | 2024-06-30 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 0de215e45d17c457ec0dc0259da393c034c42aafce82c2f99c56ce244be01a51 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 6284000000 | null | 2024-03-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 0e461aff33add04006ff575f028514fed925354f4635c884c1790f0095af2f23 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1302000000 | 2024-04-01 | 2024-06-30 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 10d56ea451f2d9c6223252a82678ccf1f0a4e63c0d9a3d53616c9620c438d8d6 | us-gaap:Assets | Total assets | USD | 73214000000 | null | 2023-12-31 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 10e22f54619a2da0653071501b94ed4b01fb241d78939dddf55041f474e34ef1 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 7616000000 | null | 2024-12-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 1345e04e0290d2a88e877456f6d631d551630928736d5eea6d2d2a092663f55f | us-gaap:Assets | Total assets | USD | 74438000000 | null | 2022-12-31 | 2023-11-01 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-035957 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 13a1606da434190308401ae9305062fc91bf64517b11fe59eceaa0a95b7e4faf | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 6896000000 | null | 2023-12-31 | 2024-02-16 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-005348 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 15d0f0b1c630241128bda1015ae1117679d17ce92049f001d44af772ca26daff | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 30976000000 | 2024-01-01 | 2024-09-30 | 2025-10-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-047131 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 165ff56993eb4ce842676526f4a53cea0153720a10d63beef5feda5131fc1b28 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 19725000000 | 2023-01-01 | 2023-06-30 | 2023-08-03 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-027203 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 16981b8aa0c2b6fcb26ec352c5aadf8d77601f69fa85501b147df30d3dd01a80 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 20341000000 | 2024-01-01 | 2024-06-30 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 1a656b50afcc44c655f531a7f82138456bd277c60c35efc6231da191791e3ba1 | us-gaap:Assets | Total assets | USD | 81414000000 | null | 2024-12-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 1c21fafc8319d0c6285bc5dfe3a7748f09823f825fcfeff2180f9fc142d3faa9 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 7511000000 | null | 2025-09-30 | 2025-10-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-047131 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 1ccba493a3e5f6746a931d6fafeb3ec0a312db489bb69ed10c93b8a2ef254550 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 7616000000 | null | 2024-12-31 | 2025-10-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-047131 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 1d5fc5d651754244c5a9d19406007475ac5c5ae6ca8ccfd29c8c293787e935ae | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 2202000000 | 2023-01-01 | 2023-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 1e8d2dceb2179fd351dff0b68844427e79251d921a0d04d90b73a5ff5668226b | us-gaap:NetIncomeLoss | Net income / loss | USD | 1225000000 | 2024-01-01 | 2024-03-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 20f417a8d52eeef293acb73b7225fa7f69fec38c862299db638d48cf9bd317be | us-gaap:NetIncomeLoss | Net income / loss | USD | 6933000000 | 2022-01-01 | 2022-12-31 | 2024-02-16 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-005348 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 229b95686a34645721cb8e9c1b0a7815d458585fc3af52210a84b02ab547d201 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 2202000000 | 2023-01-01 | 2023-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 28ca9fda1c894e44525236ec032df40df6c7c0fd3aebc2063a36a5f0b1e4639a | us-gaap:Assets | Total assets | USD | 72467000000 | null | 2024-03-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2b5881e3b88a6557458aeab867cf4c4afb85d848b939d8e9d49cbc966a941958 | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 7261000000 | 2023-01-01 | 2023-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2cd8bd39e0fdb3ac041541448b84d413011d0e8b5033691acb852a70bc8ca4db | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 6896000000 | null | 2023-12-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2dbc0931c64514b7d31f403a4fa57260acf25d3bba8f810d15bf534d1a75d14d | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 1417000000 | 2025-01-01 | 2025-03-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2dda0b0212e433df8a19c1a0611e88ad99da0d2d8d3650e2efbf28dab2825497 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 9882000000 | null | 2022-12-31 | 2024-02-16 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-005348 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2e5120a5ce793ad00270dfbb4febc3e252af1260fa7cd4fa94113999f9b4bcc9 | us-gaap:Assets | Total assets | USD | 74438000000 | null | 2022-12-31 | 2023-05-04 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-015699 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2f16973bf06f3d7f407764a32b01dbfecfc328396c6aceb470b3bb10cfe29a57 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 40109000000 | 2023-01-01 | 2023-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2f17fee1ee66eae1876bf7670ce33ae380c8d509f0eb329a60ec596855bfd2b8 | us-gaap:NetIncomeLoss | Net income / loss | USD | 6933000000 | 2022-01-01 | 2022-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2f55714d6e06a37938aad966cbc8cf1aee976a2231e04e03e77e2aa9bd904be4 | us-gaap:NetIncomeLoss | Net income / loss | USD | 13402000000 | 2024-01-01 | 2024-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2fe00cbcef8c2fe3f78b46474b47603411a2ef3d325ef68d607494ff572c2997 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1225000000 | 2024-01-01 | 2024-03-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 2ffb3aa292baaa77418c274235dc323142fa42455cfca69ecf3a03955008982c | us-gaap:Assets | Total assets | USD | 81414000000 | null | 2024-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 325d41f23f8e753d620e631382ddc6eed6c750159b6613b7ef00808fc25be723 | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 8558000000 | 2024-01-01 | 2024-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 34ec4345ca2de13cbc406292dfe94a334325ece5f3c6b09ee5bf2416b6578d4d | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 2985000000 | 2024-01-01 | 2024-06-30 | 2025-07-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-036720 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 370c66c6b632717b4bbbcc924ee7592dd49fe7f20126b365ed9ecf03a5f76bff | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 9747000000 | 2023-01-01 | 2023-03-31 | 2023-05-04 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-015699 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 37c02682c93e32396d0e4205bc3c758aa82a65f6d733d5448e10ea3880c140c4 | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 9581000000 | 2022-01-01 | 2022-12-31 | 2024-02-16 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-005348 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 3b519af5be797e9f9dce7bf4d0a66305c9644b0c2f474d724a098af9de229451 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 10635000000 | 2024-07-01 | 2024-09-30 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 3f3829e43372cda913d0942b410bf501e06f296b0ac51ed4e7c5b400b41acf34 | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 4223000000 | 2023-01-01 | 2023-09-30 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 3fb9610e8148732cd7b5a964f0f53a765f9515284d2587b04a3b0d1da7f54aaa | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 7835000000 | null | 2023-06-30 | 2023-08-03 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-027203 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 4272bdbc9b81b99b51da8d175f78639253ae4ce43c7cd5b3fb4edc71cc67c5a9 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1325000000 | 2025-01-01 | 2025-03-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 43261009174ffe05f1941fc8ec424914007d5f6c40566068e6d95325d46bcac7 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 9882000000 | null | 2022-12-31 | 2023-02-17 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-004026 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 43c2fcf2e75ee4d60cd215bf523ed4352204ee11234df624dc828d96b8df6e66 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1325000000 | 2025-01-01 | 2025-03-31 | 2026-04-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-028357 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 455e9b6b162fefdb22170e561f81d3a6a1797d18b7f9c2a47b205c78ce754d85 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 7616000000 | null | 2024-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 45ba65f8e32e80facb15e01679fc1fc75bbb0894222cada4068bc8d8166b69b7 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 11369000000 | 2025-07-01 | 2025-09-30 | 2025-10-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-047131 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 4649d6c1106a0754991e1127c6aeb8903b93d48e07889fbe3bdd155d3700fc54 | us-gaap:Assets | Total assets | USD | 81448000000 | null | 2025-03-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 466b4db242f96b22c4ca38a88145650c874688fb1d864d0512fb34fc4865b00a | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 1143000000 | 2023-01-01 | 2023-03-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 4787aaa058dde866b076bc94f7ff59da00ad6ce91840b9b8ab4073e66f4b2104 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 1482000000 | 2025-01-01 | 2025-09-30 | 2025-10-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-047131 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 48764d1f65bef9c2b4a9b776f5e7f4ad39c982ad2bacebe99a086eec61df8153 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 7616000000 | null | 2024-12-31 | 2025-07-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-036720 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 4a5ec5d6846e9fb0d21182c45c87d74867b36e7d97b3a1686560be856dfab74b | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 9882000000 | null | 2022-12-31 | 2023-08-03 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-027203 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 4add278cc873547a47ac63b4637b917d27405fb237a911cfb1c7c5375ca8f30a | us-gaap:Assets | Total assets | USD | 72090000000 | null | 2023-09-30 | 2023-11-01 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-035957 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 4bbcf1195ebf024260d8b533e11ebdc33415b0612514a9bcd5b043eabd3ec712 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 9161000000 | null | 2023-03-31 | 2023-05-04 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-015699 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 4c753af9ea158dd215d318c53e4be96caebb2fb786041af1e096a25f91459d6b | us-gaap:Assets | Total assets | USD | 81414000000 | null | 2024-12-31 | 2025-07-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-036720 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 4dc8c97394044b0f57fc41c6d35ce1b0cf4f21dc6cd38d2f11ccda410c7046c5 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 931000000 | 2024-01-01 | 2024-06-30 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 52314a9bfb0f936be022e0d39d2bc5d759bb9e1a65b2f7fd86be9d882739f89b | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 43653000000 | 2022-01-01 | 2022-12-31 | 2024-02-16 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-005348 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 52c0842320aed99e60fa007de553be59210e82b3db88405ab562e286bcb2568e | us-gaap:Assets | Total assets | USD | 73214000000 | null | 2023-12-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 5311a129428bb6aa5c7aa26be51cdbee63b44a3a83475fde47af591ebae5ecc8 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 931000000 | 2024-01-01 | 2024-06-30 | 2025-07-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-036720 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 5595f39eab3e1796f0283b2bc54f37792d4974a046345468317ee78577e821b6 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 9964000000 | 2024-01-01 | 2024-03-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 5623856147dcbadde486c7f5343299c60ba594938c04cb32dac4ca50a33e0a70 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1375000000 | 2023-04-01 | 2023-06-30 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 57f8a2d0821df0da55466cdd2443d471771dbc968ce6b4498c5ec1c321833245 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 1447000000 | 2023-01-01 | 2023-09-30 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 5b97e6cfa300d26397976f2e567d34f6f11da8169dc2523e0c9799b44bf57f6c | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 2171000000 | 2025-01-01 | 2025-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 5f77238984f90cd7e30df5e9c255bf9784ca9ff1176bee3637f6c7d80cd6cf6d | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 6987000000 | null | 2024-06-30 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 6184fa5bbd08b132954218472b353fc55a39be9db9dcac50389a0e3d846bb807 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 43653000000 | 2022-01-01 | 2022-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 650236775388b50604f55dfc2f76d4897f0f9842823b924e252d9cd5e1d7ccbe | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 10143000000 | 2023-07-01 | 2023-09-30 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 65ede59ce9a30bec4af13c457bfc3e1c1bac7a0675c8d7bccf4f5d4ac2299f4b | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 484000000 | 2025-01-01 | 2025-03-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 66d32fcbbf57f50d2d2c78ab1f4ac5319c400c9aac8d381abd656e8f3f29714b | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 4223000000 | 2023-01-01 | 2023-09-30 | 2023-11-01 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-035957 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 6967ebbd2dec8da87e578209abc5538004fc9427129fc0ec42659f585e35040b | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 484000000 | 2025-01-01 | 2025-03-31 | 2026-04-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-028357 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 69ca633d522eebb67fd9c5d6102dd62f49b62383c0dd266c26bd09aa6766e761 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1318000000 | 2023-01-01 | 2023-03-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 6cff8229a06def0a8afc4172a1174b8461ba5f645a297988ad54056f83e744ce | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 10635000000 | 2024-07-01 | 2024-09-30 | 2025-10-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-047131 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 6d0b200f6b25d1eead6a289db25f8d23c32f8cfdd9b8f77eb3ec92638141cedc | us-gaap:NetIncomeLoss | Net income / loss | USD | 4129000000 | 2023-01-01 | 2023-09-30 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 6da6f01e38d9ca2a293240cb159dcb775b7090aae29aac6440bd9443770d85a6 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 398000000 | 2024-01-01 | 2024-03-31 | 2025-04-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-021090 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025021090/0001628280-25-021090-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 6e58e55a8718ae34826b845f8bca7e82a2ef1f7efe7d689c965ba865849fb037 | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 1143000000 | 2023-01-01 | 2023-03-31 | 2023-05-04 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-015699 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023015699/0001628280-23-015699-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 6f60aae301297003309e3b4ecd03de9c46ba1d3c839a25314f4ffb90710fed7f | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 41950000000 | 2024-01-01 | 2024-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 6fb07bcf2919043d55f7bcd588855a8517f5e4b61536274b25d460d02a903840 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 6803000000 | null | 2026-03-31 | 2026-04-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-028357 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 728c41db70cfd8dbb396030780a4d265176f0b4f90c81e4a747b887335342e47 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 6896000000 | null | 2023-12-31 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 7498ebec6dca1abf02fe90748894557ec6ff6d6c1a58fc1db7bf6b29ad671b9f | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 7261000000 | 2023-01-01 | 2023-12-31 | 2024-02-16 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-005348 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 74f03ca632b889a6ce49b3bd59bbff6e28eb48a74c9b213907719acdc7c4bcc3 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 1487000000 | 2024-01-01 | 2024-09-30 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 75966d1d666ab77e73e0456831516630c04dde53712562b073cb64ff0f323be4 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1779000000 | 2025-04-01 | 2025-06-30 | 2025-07-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-036720 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 75c63cb06cc4f05f5e94a558d426477ccf4d34b85e8693f8f358977ec6cb0ba7 | us-gaap:Assets | Total assets | USD | 81414000000 | null | 2024-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 780c2af7d42efadb793af02e11bb221c9ee9acb1d3808be91a93e26416e96f84 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 40109000000 | 2023-01-01 | 2023-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 799cd6f3439e459b2de932825ec215e594421b9cda1b2015c4a125d02dd9bdf0 | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 19725000000 | 2023-01-01 | 2023-06-30 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 7e263c83a8379636116b076e0fafff17b0a1d12016193390d085c07ea065596a | us-gaap:NetIncomeLoss | Net income / loss | USD | 4173000000 | 2024-01-01 | 2024-09-30 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 7e9b3d73cc9b57a097755cb76910a6589483e22dc9a08e7788e07dd2e1016c9d | us-gaap:NetIncomeLoss | Net income / loss | USD | 5723000000 | 2023-01-01 | 2023-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 7ffd4b181817d7ed09ff712844d30c866161bf051a29e26bf3ba35c028eacddd | us-gaap:Assets | Total assets | USD | 86713000000 | null | 2025-12-31 | 2026-04-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-028357 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 8094509a9cb8393968d1aefc287fc35f2cd9811b16d13a7389fe86204af33d04 | us-gaap:CashAndCashEquivalentsAtCarryingValue | Cash and cash equivalents | USD | 7558000000 | null | 2024-09-30 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 8106e9145612ed918c4476b1987c70e9d9ac61647a1698808634927e018df943 | us-gaap:Assets | Total assets | USD | 86713000000 | null | 2025-12-31 | 2026-02-20 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-010185 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828026010185/0001628280-26-010185-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 812c77b233c8f1bbad482d410d47029f195831851a975fc40469e447ef0c8f41 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 986000000 | 2025-01-01 | 2025-06-30 | 2025-07-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-036720 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 82669bcc02af5f8232d6cfd6a2c5a5d5ba55ef87f7209810d753ca70fb9b9d8e | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 20341000000 | 2024-01-01 | 2024-06-30 | 2025-07-30 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-036720 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025036720/0001628280-25-036720-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 83dbddbe26be834e073a1add47fe7ac0afd83f859a60c8c234f0b4b3f5da4f11 | us-gaap:NetIncomeLoss | Net income / loss | USD | 5723000000 | 2023-01-01 | 2023-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 852fd2a31f4cea9a07252c38657e3dbd41911b8e14dd4a51d93e4666fce76635 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 887000000 | 2023-01-01 | 2023-06-30 | 2023-08-03 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-027203 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 857b8d189627ae16357c4f64874f0e7bdd20ae31635caabe87492936400413d5 | us-gaap:Assets | Total assets | USD | 73214000000 | null | 2023-12-31 | 2024-10-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-044602 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024044602/0001628280-24-044602-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 864b74178c4c89628c3e95c7b29f3f8854592bae9f324818ab334ec13954bad2 | us-gaap:Assets | Total assets | USD | 73214000000 | null | 2023-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 8a3fe515b03d8eef23ae9a5c72ea9754deb79649a2fe13e72ab67780582b7350 | us-gaap:NetCashProvidedByUsedInOperatingActivities | Operating cash flow | USD | 2346000000 | 2023-01-01 | 2023-06-30 | 2023-08-03 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-027203 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023027203/0001628280-23-027203-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 8b40bb49b1dee3f442619935bb0dd943009b079b867205f25a209fbe86aee4bb | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax | Revenue | USD | 9964000000 | 2024-01-01 | 2024-03-31 | 2024-05-02 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-020011 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024020011/0001628280-24-020011-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 8b47889a4122f3603a2c059291272d15bc3836294308e6cb6af576f37a05385f | us-gaap:NetIncomeLoss | Net income / loss | USD | 4173000000 | 2024-01-01 | 2024-09-30 | 2025-10-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-047131 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828025047131/0001628280-25-047131-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 8e7ff1e3fcfbdc9ea15ad21cf188654ed599c7a8c9f6ee15ed36aad939ceb607 | us-gaap:NetIncomeLoss | Net income / loss | USD | 2693000000 | 2023-01-01 | 2023-06-30 | 2024-07-31 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-24-033740 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828024033740/0001628280-24-033740-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 8fbe61232784fd59cdfc7aa51cab770b79f6bb0a1080381a01893dbae659a130 | us-gaap:NetIncomeLoss | Net income / loss | USD | 1077000000 | 2026-01-01 | 2026-03-31 | 2026-04-29 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-26-028357 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828026028357/0001628280-26-028357-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 90a0718b614e323eec24bba1573c00b4e6df980b300098ebde96ca0fc09a98b4 | us-gaap:NetIncomeLoss | Net income / loss | USD | 4129000000 | 2023-01-01 | 2023-09-30 | 2023-11-01 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-23-035957 | 10-Q | https://www.sec.gov/Archives/edgar/data/1800/000162828023035957/0001628280-23-035957-index.htm |
0405e98882a7b4f322420e76e74a3f6d2361053a8b6e36b781981d1ebe29b030 | 2026-10-10T10:12:39Z | 0000001800 | ABBOTT LABORATORIES | 379caa4f88d38e6eabcd1242925213f54288e8b4db235fcc7bfbe2349203d113 | 2026-10-10T10:11:55Z | 2026-10-10T10:06:58Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | https://ahasignals.com/company-evidence/0000001800/ | 939ebefe892617f91186ce82fe993f80b7455f79f30012aea0990bbdd582b99b | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | Cash purchases of property, plant and equipment | USD | 2207000000 | 2024-01-01 | 2024-12-31 | 2025-02-21 | 2026-09-24T00:14:37Z | 5d751f73769f5c0a1f9bee0de16cb39d8961cf3f1ebb5558d555bb2678afb4ff | 0001628280-25-007110 | 10-K | https://www.sec.gov/Archives/edgar/data/1800/000162828025007110/0001628280-25-007110-index.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.